As the market for "femtech" products and services designed to address women's health concerns continues to expand, its male counterpart — "mentech" — is beginning to take shape in Japan.

Blackstone is buying a company that helps drugmakers run clinical trials in Japan, adding to growing interest from private equity firms in the health needs of the nation’s aging population.